Drug Type Autologous CAR-T |
Synonyms IL-13Rα2 Targeted Chimeric Antigen Receptor T Cell |
Target |
Action modulators |
Mechanism IL-13Rα2 modulators(Interleukin-13 receptor subunit alpha-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Phase 1 | China | 21 Mar 2024 |